VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 21 filers reported holding VBI VACCINES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $242 | -9.7% | 799,403 | +16.5% | 0.00% | – |
| Q4 2022 | $268 | -100.0% | 686,436 | -25.1% | 0.00% | -100.0% |
| Q3 2022 | $647,000 | +1.4% | 915,990 | +16.0% | 0.00% | 0.0% |
| Q2 2022 | $638,000 | +123.1% | 789,500 | +358.7% | 0.00% | – |
| Q1 2022 | $286,000 | -57.1% | 172,100 | -19.9% | 0.00% | -100.0% |
| Q2 2020 | $666,000 | +104.3% | 214,900 | -37.3% | 0.00% | – |
| Q1 2020 | $326,000 | +110.3% | 342,800 | +434.0% | 0.00% | – |
| Q3 2018 | $155,000 | -60.4% | 64,200 | -29.8% | 0.00% | – |
| Q4 2017 | $391,000 | +698.0% | 91,500 | +544.4% | 0.00% | – |
| Q3 2016 | $49,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |